ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,309Medicare Part D Prescriptions Filled, Including Refills

Rank: 294 out of 676

$379K Total Retail Price of All Prescriptions

Rank: 288 out of 676

240 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 240 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

35% of this provider’s 240 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 4,935 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 319 208 S3 1 1
AMLODIPINE BESYLATE 248 205 2 3
GABAPENTIN 239 180 3 10
LISINOPRIL 218 128 4 5
SIMVASTATIN 214 142 5 6
OMEPRAZOLE 211 125 6 2
METFORMIN HCL 172 121 7 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 164 116 8 16
PRAVASTATIN SODIUM 155 114 9 11
CARVEDILOL 150 131 10 15
FUROSEMIDE 141 114 11 4
ZOLPIDEM TARTRATE 129 56 12 21
POTASSIUM CHLORIDE 125 102 13 9
MELOXICAM 117 91 14 13
FLUTICASONE PROPIONATE 112 83 15 49
CITALOPRAM HBR 104 52 16 17
LEVOTHYROXINE SODIUM 100 73 17 7
METOPROLOL TARTRATE 97 96 18 22
AMITRIPTYLINE HCL 95 47 R 19 46
NEXIUM 90 23 20 23
DOXAZOSIN MESYLATE 89 52 21 116
FLUCONAZOLE 84 53 22 115
LOSARTAN-HYDROCHLOROTHIAZIDE 83 56 23 51
ATENOLOL 79 28 24 25
HYDROCHLOROTHIAZIDE 77 49 25 12
DICLOFENAC SODIUM 75 48 26 142
LANTUS 74 42 27 55
PAROXETINE HCL 72 59 28 65
CRESTOR 70 58 29 29
GLIPIZIDE 64 55 30 81
LEVOFLOXACIN 62 38 31 91
JANUVIA 62 34 31 78
LOVASTATIN 61 41 33 33
LOSARTAN POTASSIUM 59 42 34 34
CIPROFLOXACIN HCL 57 45 35 45
SERTRALINE HCL 54 36 36 26
JANUMET 53 50 37 167
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.